Clinical Trial Update: Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration [Phase 3]

View source ↗

Summary

Kissei Pharmaceutical's Phase 3 confirmatory trial of KPS-0373 for spinocerebellar degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Degeneration

Drugs mentioned

• KPS-0373

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Spinocerebellar Degeneration | Phase 3 | Status: RECRUITING